BRCA1 mRNA Expression as a Predictive and Prognostic Marker in Advanced Esophageal Squamous Cell Carcinoma Treated with Cisplatin- or Docetaxel-Based Chemotherapy/Chemoradiotherapy

• Yong Gao,

  Affiliation Department of Medical Oncology, Huai'an First People's Hospital, Nanjing Medical University, Huai'an, China

  ⨯
• Jing Zhu,

  Affiliation Department of Medical Oncology, Huai'an First People's Hospital, Nanjing Medical University, Huai'an, China

  ⨯
• Xiaohui Zhang,

  Affiliation Department of Medical Oncology, Huai'an First People's Hospital, Nanjing Medical University, Huai'an, China

  ⨯
• Qingquan Wu,

  Affiliation Department of Thoracic Surgery, Huai'an First People's Hospital, Nanjing Medical University, Huai'an, China

  ⨯
• Shaoning Jiang,

  Affiliation Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama, United States of America

  ⨯
• Yangqing Liu,

  Affiliation Department of Medical Oncology, Huai'an First People's Hospital, Nanjing Medical University, Huai'an, China

  ⨯
• Zhibin Hu,

  Affiliation Department of Epidemiology and Biostatistics, Nanjing Medical University, Nanjing, China

  ⨯
• Baorui Liu ,

  * E-mail: hayycxf@163.com (XC); baoruiliu@hotmail.com (BL)

  Affiliation The Comprehensive Cancer Center, Gulou School of Clinical Medicine, Nanjing Medical University, Nanjing, China

  ⨯
• Xiaofei Chen

  * E-mail: hayycxf@163.com (XC); baoruiliu@hotmail.com (BL)

  Affiliation Department of Medical Oncology, Huai'an First People's Hospital, Nanjing Medical University, Huai'an, China

  ⨯